GOLGA6D
gene geneOn this page
Summary
GOLGA6D (golgin A6 family member D, HGNC:32204) is a protein-coding gene on chromosome 15q24.2, encoding Golgin subfamily A member 6D (P0CG33). It is a selective cancer dependency (DepMap: 22.4% of cell lines).
Predicted to be involved in Golgi organization. Predicted to be located in Golgi apparatus. Predicted to be active in Golgi cis cisterna; Golgi cisterna membrane; and cis-Golgi network.
Source: NCBI Gene 653643 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 89 total
- Cancer dependency (DepMap): dependent in 22.4% of screened cell lines
- MANE Select transcript:
NM_001145224
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32204 |
| Approved symbol | GOLGA6D |
| Name | golgin A6 family member D |
| Location | 15q24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000140478 |
| Ensembl biotype | protein_coding |
| Entrez | 653643 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000434739
RefSeq mRNA: 1 — MANE Select: NM_001145224
NM_001145224
CCDS: CCDS45308
Canonical transcript exons
ENST00000434739 — 18 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001762458 | 75294348 | 75295530 |
| ENSE00002435111 | 75287629 | 75287667 |
| ENSE00002436093 | 75289592 | 75289699 |
| ENSE00002448664 | 75292565 | 75292640 |
| ENSE00002449876 | 75291166 | 75291234 |
| ENSE00002452268 | 75289892 | 75289979 |
| ENSE00002459521 | 75287929 | 75287979 |
| ENSE00002469562 | 75293915 | 75294018 |
| ENSE00002473647 | 75284650 | 75284769 |
| ENSE00002477542 | 75286693 | 75286773 |
| ENSE00002480645 | 75289397 | 75289483 |
| ENSE00002482271 | 75290381 | 75290889 |
| ENSE00002492439 | 75288258 | 75288364 |
| ENSE00002507280 | 75294108 | 75294261 |
| ENSE00002509064 | 75293073 | 75293164 |
| ENSE00002521332 | 75293729 | 75293831 |
| ENSE00002531442 | 75288080 | 75288161 |
| ENSE00002610606 | 75282835 | 75282959 |
Expression profiles
Bgee: expression breadth broad, 43 present calls, max score 86.91.
Top tissues by expression
74 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.91 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.79 | gold quality |
| right testis | UBERON:0004534 | 76.79 | gold quality |
| testis | UBERON:0000473 | 76.51 | gold quality |
| left testis | UBERON:0004533 | 76.48 | gold quality |
| liver | UBERON:0002107 | 60.75 | gold quality |
| right lobe of liver | UBERON:0001114 | 56.84 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 51.63 | gold quality |
| cerebellum | UBERON:0002037 | 49.72 | gold quality |
| cerebellar cortex | UBERON:0002129 | 49.68 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 49.40 | gold quality |
| right coronary artery | UBERON:0001625 | 49.31 | gold quality |
| sural nerve | UBERON:0015488 | 48.97 | gold quality |
| apex of heart | UBERON:0002098 | 48.23 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 48.07 | gold quality |
| muscle of leg | UBERON:0001383 | 47.83 | gold quality |
| bone marrow cell | CL:0002092 | 47.02 | gold quality |
| gastrocnemius | UBERON:0001388 | 46.78 | gold quality |
| muscle tissue | UBERON:0002385 | 45.75 | gold quality |
| right uterine tube | UBERON:0001302 | 44.05 | silver quality |
| tibial artery | UBERON:0007610 | 43.94 | gold quality |
| popliteal artery | UBERON:0002250 | 43.87 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.23 | gold quality |
| ventricular zone | UBERON:0003053 | 40.63 | gold quality |
| endometrium | UBERON:0001295 | 40.57 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 40.49 | silver quality |
| bone marrow | UBERON:0002371 | 40.47 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 39.99 | silver quality |
| calcaneal tendon | UBERON:0003701 | 39.84 | gold quality |
| tibial nerve | UBERON:0001323 | 39.23 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.31 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
61 targeting GOLGA6D, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4795-3P | 100.00 | 74.62 | 4024 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-204-5P | 99.79 | 71.62 | 2439 |
| HSA-MIR-211-5P | 99.79 | 71.65 | 2440 |
| HSA-MIR-202-5P | 99.78 | 67.65 | 991 |
| HSA-MIR-1299 | 99.77 | 71.24 | 2389 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-1179 | 99.71 | 68.70 | 1040 |
| HSA-MIR-10393-5P | 99.65 | 68.01 | 1368 |
| HSA-MIR-1287-3P | 99.63 | 66.93 | 492 |
| HSA-MIR-1260A | 99.61 | 66.67 | 1098 |
| HSA-MIR-1260B | 99.61 | 66.67 | 1098 |
| HSA-MIR-2113 | 99.58 | 71.22 | 1521 |
| HSA-MIR-3682-3P | 99.58 | 67.63 | 865 |
| HSA-MIR-6832-3P | 99.52 | 70.44 | 1726 |
| HSA-MIR-4672 | 99.50 | 71.58 | 2893 |
| HSA-MIR-4677-3P | 99.49 | 67.91 | 1246 |
| HSA-MIR-5584-5P | 99.49 | 68.22 | 2814 |
| HSA-MIR-3182 | 99.40 | 68.15 | 2454 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 22.4% of screened cell lines.
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | golga2 | ENSDARG00000063197 |
| mus_musculus | Golga2 | ENSMUSG00000002546 |
| rattus_norvegicus | Golga2l1 | ENSRNOG00000050262 |
| drosophila_melanogaster | GM130 | FBGN0034697 |
| caenorhabditis_elegans | WBGENE00018017 |
Paralogs (18): GOLGA8F (ENSG00000153684), GOLGA6A (ENSG00000159289), GOLGA2 (ENSG00000167110), GOLGA6C (ENSG00000167195), GOLGA8A (ENSG00000175265), GOLGA8Q (ENSG00000178115), GOLGA8J (ENSG00000179938), GOLGA8G (ENSG00000183629), GOLGA8R (ENSG00000186399), GOLGA8M (ENSG00000188626), GOLGA8O (ENSG00000206127), GOLGA6B (ENSG00000215186), GOLGA8B (ENSG00000215252), GOLGA8N (ENSG00000232653), GOLGA8K (ENSG00000249931), GOLGA8T (ENSG00000261247), GOLGA8S (ENSG00000261739), GOLGA8H (ENSG00000261794)
Protein
Protein identifiers
Golgin subfamily A member 6D — P0CG33 (reviewed: P0CG33)
All UniProt accessions (1): P0CG33
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the GOLGA6 family.
RefSeq proteins (1): NP_001138696* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR024858 | GOLGA | Family |
| IPR043976 | GOLGA_cons_dom | Domain |
Pfam: PF15070
UniProt features (7 total): region of interest 3, compositionally biased region 2, chain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0CG33-F1 | 74.46 | 0.50 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 23 (showing top):
GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_GOLGI_ORGANIZATION, GOCC_GOLGI_STACK, GOCC_GOLGI_CISTERNA, GOCC_CIS_GOLGI_NETWORK, GOCC_GOLGI_CISTERNA_MEMBRANE, GOCC_ORGANELLE_SUBCOMPARTMENT, GOCC_GOLGI_CIS_CISTERNA, MIR520D_5P, MIR524_5P, MIR4719, MIR3143, MIR4672, MIR2113, MIR10522_5P
GO Biological Process (1): Golgi organization (GO:0007030)
GO Molecular Function (0):
GO Cellular Component (4): Golgi cis cisterna (GO:0000137), cis-Golgi network (GO:0005801), Golgi cisterna membrane (GO:0032580), Golgi apparatus (GO:0005794)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| Golgi cisterna | 2 |
| intracellular membrane-bounded organelle | 2 |
| organelle organization | 1 |
| endomembrane system organization | 1 |
| Golgi apparatus | 1 |
| organelle membrane | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
Protein interactions and networks
STRING
118 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GOLGA6D | ITSN2 | Q9NZM3 | 238 |
| GOLGA6D | RPL29 | P47914 | 161 |
| GOLGA6D | BTBD18 | B2RXH4 | 161 |
| GOLGA6D | DDX6 | P26196 | 161 |
| GOLGA6D | SHC1 | P29353 | 160 |
| GOLGA6D | GOLGA7 | Q7Z5G4 | 154 |
| GOLGA6D | ITSN1 | Q15811 | 151 |
| GOLGA6D | USO1 | O60763 | 132 |
| GOLGA6D | TRIP11 | Q15643 | 132 |
| GOLGA6D | GORASP2 | Q9H8Y8 | 128 |
| GOLGA6D | GORASP1 | Q9BQQ3 | 128 |
| GOLGA6D | STX5 | Q13190 | 115 |
| GOLGA6D | GOLGB1 | Q14789 | 114 |
| GOLGA6D | VPS35 | Q96QK1 | 109 |
| GOLGA6D | GOSR1 | O95249 | 106 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| M | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (2): CLRN3 (Cross-Linking-MS (XL-MS)), DBN1 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A2AM05, A6NC78, A6NCC3, A6NDK9, A6NDN3, A6NJZ7, A6NMD2, A6NN73, A6NNM3, A7E2F4, A8MQT2, D6RF30, F8WBI6, H3BPF8, H3BQL2, H3BSY2, H3BV12, I6L899, P0CG33, P0CJ92, P0DO97, P0DX52, P0DX53, P54257, Q0D2H9, Q0KK56, Q2M243, Q3T1I3, Q3TCJ8, Q3V0F0, Q5BK57, Q5XHZ2, Q6AW69, Q6AXN6, Q6PHN1, Q7TME2, Q8BG89, Q8BGY3, Q8C0G2, Q8K389
Diamond homologs: A0A1B0GV03, A1IH00, A6NC78, A6NCC3, A6NDK9, A6NDN3, A6NEF3, A6NEM1, A6NI86, A6NN73, A7E2F4, A8MQT2, A8MZA4, F8WBI6, H0YKK7, H0YM25, H3BPF8, H3BSY2, H3BV12, I6L899, P0CG33, P0CJ92, P0DX00, P0DX01, P0DX02, P0DX52, P0DX53, Q08379, Q62839, Q8N7Z2, Q8N9W4, Q921M4, Q9NYA3, A6NMD2, D6RF30, H3BQL2, Q0D2H9, Q9HBQ8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
89 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 74 |
| Likely benign | 15 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2847 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:75284645:CACA:C | acceptor_loss | 1.0000 |
| 15:75284647:CA:C | acceptor_loss | 1.0000 |
| 15:75284648:A:AG | acceptor_gain | 1.0000 |
| 15:75284648:AGC:A | acceptor_loss | 1.0000 |
| 15:75284649:G:GA | acceptor_gain | 1.0000 |
| 15:75284649:G:GT | acceptor_loss | 1.0000 |
| 15:75284649:GCT:G | acceptor_gain | 1.0000 |
| 15:75284649:GCTA:G | acceptor_gain | 1.0000 |
| 15:75284748:T:TA | donor_gain | 1.0000 |
| 15:75284749:G:GA | donor_gain | 1.0000 |
| 15:75284765:GGGAT:G | donor_gain | 1.0000 |
| 15:75284766:GGAT:G | donor_gain | 1.0000 |
| 15:75284766:GGATG:G | donor_gain | 1.0000 |
| 15:75284767:G:GT | donor_gain | 1.0000 |
| 15:75284767:G:T | donor_gain | 1.0000 |
| 15:75284767:GAT:G | donor_gain | 1.0000 |
| 15:75284770:G:GG | donor_gain | 1.0000 |
| 15:75286653:A:AG | acceptor_gain | 1.0000 |
| 15:75286654:C:G | acceptor_gain | 1.0000 |
| 15:75286655:A:AG | acceptor_gain | 1.0000 |
| 15:75286666:A:AG | acceptor_gain | 1.0000 |
| 15:75286667:A:G | acceptor_gain | 1.0000 |
| 15:75286683:T:G | acceptor_gain | 1.0000 |
| 15:75287665:G:GT | donor_gain | 1.0000 |
| 15:75287668:G:GG | donor_gain | 1.0000 |
| 15:75288353:G:GT | donor_gain | 1.0000 |
| 15:75288361:CAGGG:C | donor_loss | 1.0000 |
| 15:75288362:AGGG:A | donor_loss | 1.0000 |
| 15:75288363:GG:G | donor_gain | 1.0000 |
| 15:75288364:GG:G | donor_gain | 1.0000 |
AlphaMissense
4557 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:75288093:T:C | L130P | 0.944 |
| 15:75288114:T:C | L137S | 0.919 |
| 15:75289944:T:C | L271P | 0.903 |
| 15:75288107:G:C | A135P | 0.901 |
| 15:75290453:T:C | L307P | 0.897 |
| 15:75290486:T:C | L318P | 0.891 |
| 15:75286751:T:C | L88P | 0.883 |
| 15:75288155:T:C | F151L | 0.883 |
| 15:75288157:C:A | F151L | 0.883 |
| 15:75288157:C:G | F151L | 0.883 |
| 15:75287929:G:C | A109P | 0.875 |
| 15:75289626:G:C | R229P | 0.871 |
| 15:75289669:G:C | W243C | 0.871 |
| 15:75289669:G:T | W243C | 0.871 |
| 15:75289667:T:A | W243R | 0.868 |
| 15:75289667:T:C | W243R | 0.868 |
| 15:75290443:G:C | A304P | 0.858 |
| 15:75288263:T:C | S155P | 0.850 |
| 15:75288102:A:T | E133V | 0.834 |
| 15:75294174:T:C | F623L | 0.818 |
| 15:75294176:C:A | F623L | 0.818 |
| 15:75294176:C:G | F623L | 0.818 |
| 15:75288103:A:C | E133D | 0.810 |
| 15:75288103:A:T | E133D | 0.810 |
| 15:75289605:T:C | L222P | 0.806 |
| 15:75288093:T:A | L130H | 0.795 |
| 15:75287660:T:C | L106P | 0.784 |
| 15:75289668:G:C | W243S | 0.784 |
| 15:75288146:G:C | A148P | 0.783 |
| 15:75289637:G:C | A233P | 0.782 |
dbSNP variants (sampled 300 via entrez): RS1001455142 (15:75275621 G>A), RS1002855553 (15:75295910 C>T), RS1002886623 (15:75295672 C>CT), RS1002918073 (15:75275812 A>C), RS1004710568 (15:75295945 C>A), RS1005928488 (15:75294129 G>A,C), RS1006128424 (15:75293661 G>A), RS1006718049 (15:75280665 G>A), RS1007348038 (15:75286163 T>C), RS1011570887 (15:75295623 G>A,C,T), RS1012206138 (15:75295882 A>C,G), RS1012533824 (15:75289499 G>A), RS1013535190 (15:75275679 T>G), RS1013754531 (15:75279043 T>A,C), RS1016476271 (15:75295965 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007725_8 | Serum uric acid levels | 1.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004761 | uric acid measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.